ResMed's New Product Launch Drives New Personalized Experiences in Sleep Breathing

On October 26, ResMed, a global leader in digital health and cloud-connected medical devices, released the Lumis 100 VPAP ST dual-level
positive pressure ventilation therapy machine.
The new product will be fully available from October 28, dedicated to opening a new personalized ventilation experience for patients with symptoms such as obstructive sleep apnea syndrome (OSAS) and chronic obstructive pulmonary disease (COPD), empowering the patient experience upgrade and the development of
the sleep breathing industry.

Liu Ding, General Manager of ResMed China, said, "ResMed has been deeply engaged in the field of sleep and respiratory health for more than 30 years, and the release of this new product demonstrates ResMed's consistent philosophy of adhering to innovative research and development and insight into consumer health needs, which is of great significance
to meet the customized needs of patients and explore the whole process of personalized services.
”

According to statistics, obstructive sleep apnea syndrome (OSAS) and chronic obstructive pulmonary disease (COPD) are two common chronic diseases
that seriously endanger human health.
In China, the prevalence of COPD in adults aged 20 years and older is 8.
6%, and the prevalence rate in people over 40 years old is as high as 13.
7%, with nearly 100 million
patients.
The number of OSA patients in China has also reached 176 million, of which more than 66 million patients require active treatment
.

ResMed's Lumis 100ST has multiple highlights and will open up a new personalized treatment experience
for more patients.
The new products use iBR, Vsync, TiControl and other technologies, including the excellent intelligent backup frequency iBR technology, which automatically adapts to the changes in respiratory rate of day and night and different stages of the patient, and achieves better intelligent breathing synchronization
according to the needs of patients.

The Lumis 100ST maintains the high standards of ResMed product technology, maximizing the experience and therapeutic outcomes
.
The simple and intuitive on-screen display allows patients to view usage and obtain ventilation treatment reports
in a timely and convenient manner.
Its operating noise is as low as 27dB, providing patients with a quiet and comfortable treatment experience
.
At the same time, the newly upgraded pipeline optimizes the oxygen connection and delivery mode, and also allows the patient's oxygen intake concentration to be relatively higher and more stable, with better and safer
results.

In addition, the Lumis 100ST works with the AirView cloud remote data management platform to realize PC and mobile phone viewing and management, which allows professionals to easily "connect" with the patient's treatment progress, find equipment and patient problems in time, and adjust them, thereby improving patient dependence
.

Since entering the Chinese market in 2007, ResMed has continuously introduced innovative products and solutions to continuously improve patient compliance and treatment experience
in China.
In the future, ResMed will continue to be deeply rooted in the field of sleep respiratory health and is committed to improving the quality of life of
250 million people by 2025.